News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
266,773 Results
Type
Article (14198)
Company Profile (282)
Press Release (252293)
Section
Business (79514)
Career Advice (153)
Deals (13227)
Drug Delivery (35)
Drug Development (50446)
Employer Resources (31)
FDA (5715)
Job Trends (5129)
News (144400)
Policy (10028)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (1)
2024 BioMidwest Digital (4)
2024 Bio NC Digital (4)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (11)
2024 Biotech Beach Digital (5)
2024 Biotech Beach Standard (3)
2024 Genetown Digital (7)
2024 Genetown Standard (7)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (4)
2024 Pharm Country Standard (4)
2025 BioForest Digital (3)
2025 Lone Star Bio Digital (3)
2026 BioMidwest Elite (1)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Elite (1)
Academia (910)
Accelerated approval (2)
Adcomms (12)
Allergies (49)
Alliances (21640)
ALS (61)
Alzheimer's disease (835)
Antibody-drug conjugate (ADC) (88)
Approvals (5732)
Artificial intelligence (112)
Autoimmune disease (13)
Automation (5)
Bankruptcy (104)
Best Places to Work (4562)
BIOSECURE Act (5)
Biosimilars (40)
Biotechnology (232)
Bladder cancer (45)
Brain cancer (20)
Breast cancer (142)
Cancer (1317)
Cardiovascular disease (112)
Career advice (132)
Career pathing (2)
CAR-T (107)
Cell therapy (308)
Cervical cancer (8)
Clinical research (40913)
Collaboration (499)
Compensation (226)
Complete response letters (13)
COVID-19 (1034)
CRISPR (37)
C-suite (146)
Cystic fibrosis (76)
Data (1379)
Denatured (11)
Depression (29)
Diabetes (126)
Diagnostics (1294)
Digital health (3)
Diversity (2)
Diversity, equity & inclusion (9)
Drug discovery (79)
Drug pricing (28)
Drug shortages (3)
Duchenne muscular dystrophy (83)
Earnings (29691)
Editorial (17)
Employer branding (4)
Employer resources (29)
Events (48183)
Executive appointments (410)
FDA (6344)
Featured Employer (31)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (470)
Gene editing (89)
Generative AI (9)
Gene therapy (234)
GLP-1 (358)
Government (1074)
Grass and pollen (2)
Guidances (18)
Healthcare (6590)
Huntington's disease (21)
IgA nephropathy (21)
Immunology and inflammation (80)
Indications (18)
Infectious disease (1096)
Inflammatory bowel disease (110)
Inflation Reduction Act (8)
Influenza (18)
Intellectual property (58)
Interviews (17)
IPO (7263)
IRA (11)
Job creations (860)
Job search strategy (127)
Kidney cancer (6)
Labor market (4)
Layoffs (203)
Leadership (2)
Legal (1386)
Liver cancer (30)
Lung cancer (187)
Lymphoma (84)
Machine learning (1)
Management (7)
Manufacturing (116)
MASH (49)
Medical device (2589)
Medtech (2590)
Mergers & acquisitions (6260)
Metabolic disorders (366)
Multiple sclerosis (51)
NASH (13)
Neurodegenerative disease (61)
Neuropsychiatric disorders (23)
Neuroscience (1212)
NextGen: Class of 2025 (2017)
Non-profit (852)
Northern California (1567)
Now hiring (21)
Obesity (186)
Opinion (100)
Ovarian cancer (60)
Pain (40)
Pancreatic cancer (51)
Parkinson's disease (110)
Partnered (8)
Patents (112)
Patient recruitment (67)
Peanut (35)
People (25526)
Pharmaceutical (48)
Pharmacy benefit managers (5)
Phase I (14446)
Phase II (19035)
Phase III (12036)
Pipeline (741)
Podcasts (47)
Policy (38)
Postmarket research (852)
Preclinical (6067)
Press Release (30)
Prostate cancer (55)
Psychedelics (35)
Radiopharmaceuticals (212)
Rare diseases (277)
Real estate (1415)
Recruiting (12)
Regulatory (8572)
Reports (15)
Research institute (937)
Resumes & cover letters (17)
Rett syndrome (4)
RNA editing (4)
RSV (10)
Schizophrenia (56)
Series A (92)
Series B (60)
Service/supplier (1)
Sickle cell disease (39)
Southern California (1391)
Special edition (11)
Spinal muscular atrophy (117)
Sponsored (11)
Startups (1971)
State (1)
Stomach cancer (4)
Supply chain (18)
Tariffs (3)
The Weekly (35)
United States (12257)
Vaccines (205)
Venture capitalists (28)
Webinars (7)
Weight loss (105)
Women's health (15)
Worklife (2)
Date
Today (68)
Last 7 days (448)
Last 30 days (1632)
Last 365 days (19973)
2025 (4925)
2024 (20552)
2023 (22414)
2022 (26825)
2021 (27813)
2020 (23356)
2019 (16228)
2018 (11745)
2017 (13745)
2016 (11840)
2015 (14349)
2014 (10393)
2013 (7484)
2012 (7532)
2011 (7615)
2010 (7428)
Location
Africa (148)
Alabama (38)
Alaska (2)
Arizona (53)
Arkansas (5)
Asia (17226)
Australia (2920)
California (3560)
Canada (1058)
China (326)
Colorado (138)
Connecticut (143)
Delaware (88)
Europe (37050)
Florida (422)
Georgia (110)
Idaho (16)
Illinois (214)
India (9)
Indiana (86)
Iowa (1)
Japan (71)
Kansas (59)
Kentucky (5)
Louisiana (3)
Maine (11)
Maryland (446)
Massachusetts (2816)
Michigan (69)
Minnesota (137)
Mississippi (1)
Missouri (23)
Montana (14)
Nebraska (4)
Nevada (15)
New Hampshire (14)
New Jersey (892)
New Mexico (12)
New York (967)
North Carolina (525)
North Dakota (4)
Northern California (1567)
Ohio (108)
Oklahoma (9)
Oregon (21)
Pennsylvania (680)
Puerto Rico (3)
Rhode Island (15)
South America (208)
South Carolina (4)
Southern California (1391)
Tennessee (25)
Texas (412)
Utah (48)
Virginia (70)
Washington D.C. (28)
Washington State (323)
Wisconsin (13)
266,773 Results for "viridian therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - March 10, 2025
March 10, 2025
·
3 min read
Press Releases
Viridian Therapeutics Highlights Recent Progress and Reports Fourth Quarter and Full Year 2024 Financial Results
February 27, 2025
·
15 min read
Genetown
Viridian Therapeutics Announces Participation in Upcoming June Investor Conferences
Viridian Therapeutics, Inc. today announced that senior management will participate in the following upcoming investor conferences in June.
May 31, 2024
·
2 min read
Press Releases
Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - February 6, 2025
February 6, 2025
·
2 min read
Genetown
Viridian Therapeutics to Participate in Upcoming May Investor Conferences
Viridian Therapeutics, Inc. today announced that senior management will participate in the following upcoming investor conferences in May.
May 10, 2024
·
1 min read
Press Releases
Viridian Therapeutics Highlights 2025 Corporate Priorities Following Positive Phase 3 Topline Data in Thyroid Eye Disease
January 8, 2025
·
15 min read
Press Releases
Viridian Therapeutics to Webcast Veligrotug Phase 3 THRIVE-2 Topline Results on December 16, 2024
December 16, 2024
·
4 min read
Business
Viridian Therapeutics Highlights Recent Progress and Reports First Quarter 2024 Financial Results
Viridian Therapeutics, Inc., a biotechnology company focused on discovering and developing potential best-in-class medicines for serious and rare diseases, reported recent business highlights and financial results for the first quarter ending March 31, 2024.
May 8, 2024
·
11 min read
Business
Viridian Therapeutics to Webcast First Quarter 2024 Financial Results on May 8, 2024
Viridian Therapeutics, Inc. today announced it will host a webcast and conference call on Wednesday, May 8 at 8:00 a.m. ET to discuss its first quarter 2024 financial results and recent business highlights.
April 29, 2024
·
1 min read
Press Releases
Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - December 4, 2024
December 5, 2024
·
2 min read
1 of 26,678
Next
